Sensitivity of BRCA1/2 mutation testing in 466 breast/ovarian cancer families.
作者信息
Evans D G R, Bulman M, Young K, Gokhale D, Lalloo F
机构信息
Academic Unit of Medical Genetics, Regional Genetics Service, and National Genetics Reference Laboratory, St Mary's Hospital, Manchester M13 0JH, UK.
出版信息
J Med Genet. 2003 Sep;40(9):e107. doi: 10.1136/jmg.40.9.e107.
Abstract
摘要
相似文献
1
Sensitivity of BRCA1/2 mutation testing in 466 breast/ovarian cancer families.466个乳腺癌/卵巢癌家族中BRCA1/2突变检测的敏感性
J Med Genet. 2003 Sep;40(9):e107. doi: 10.1136/jmg.40.9.e107.
2
Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.巴基斯坦乳腺癌和卵巢癌患者中BRCA1和BRCA2基因突变的患病率。
Int J Cancer. 2006 Dec 15;119(12):2832-9. doi: 10.1002/ijc.22269.
3
Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome.一个患有遗传性乳腺癌和卵巢癌综合征的伊朗家族中BRCA1和BRCA2基因突变分析。
Am J Med Genet A. 2003 Mar 15;117A(3):304-5. doi: 10.1002/ajmg.a.10031.
4
Rapid, inexpensive scanning for all possible BRCA1 and BRCA2 gene sequence variants in a single assay: implications for genetic testing.在单一检测中对所有可能的BRCA1和BRCA2基因序列变异进行快速、低成本扫描：对基因检测的意义
J Med Genet. 2003 Apr;40(4):e33. doi: 10.1136/jmg.40.4.e33.
5
Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families.韩国乳腺癌和/或卵巢癌家族中BRCA1和BRCA2的种系突变。
Hum Mutat. 2002 Sep;20(3):235. doi: 10.1002/humu.9059.
6
Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.BRCA1和BRCA2突变对遗传性卵巢癌的影响。
Hum Mutat. 2007 Dec;28(12):1207-15. doi: 10.1002/humu.20599.
7
US court reverses gene patent ruling for BRCA1 and BRCA2.美国法院推翻了对BRCA1和BRCA2基因的专利裁决。
Lancet Oncol. 2011 Sep;12(9):835. doi: 10.1016/s1470-2045(11)70247-9.
8
No mutations in the XRCC2 gene in BRCA1/2-negative high-risk breast cancer families.在BRCA1/2基因阴性的高危乳腺癌家族中，XRCC2基因无突变。
Int J Cancer. 2003 Jan 1;103(1):136-7. doi: 10.1002/ijc.10766.
9
Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations.遗传性乳腺癌和卵巢癌的基因检测及美国预防医学工作组的建议。
Breast J. 2019 Jul;25(4):575-577. doi: 10.1111/tbj.13292.
10
Comprehensive BRCA1 and BRCA2 mutational profile in Lithuania.立陶宛BRCA1和BRCA2的综合突变谱
Cancer Genet. 2014 May;207(5):195-205. doi: 10.1016/j.cancergen.2014.05.002. Epub 2014 May 10.
引用本文的文献
1
Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction.对 30 个遗传性乳腺癌和卵巢癌家族的假定 BRCA1 剪接突变进行分析，确定了逃避计算机预测的外显子剪接突变。
PLoS One. 2012;7(12):e50800. doi: 10.1371/journal.pone.0050800. Epub 2012 Dec 11.
2
BRCA1/2 mutation analysis in male breast cancer families from North West England.英格兰西北部男性乳腺癌家族中的BRCA1/2基因突变分析。
Fam Cancer. 2008;7(2):113-7. doi: 10.1007/s10689-007-9153-9. Epub 2007 Jul 17.
3
Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening.BRCA1和BRCA2家族中的拟表型：修饰基因的证据及其对筛查的意义。
J Med Genet. 2007 Jan;44(1):10-15. doi: 10.1136/jmg.2006.043091. Epub 2006 Nov 1.
4
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.一种用于识别BRCA1/2基因突变可能性的新评分系统优于包括BRCAPRO在内的现有模型。
J Med Genet. 2004 Jun;41(6):474-80. doi: 10.1136/jmg.2003.017996.
Zotero 插件